Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic

Xiao-Yu Chen1, Ri-Xiang Xu1, Xin Zhou1

  • 1Department of Pharmacology, School of Pharmacy, Anhui Medical University, 81 Meishan Road, Hefei, 230032, Anhui, People's Republic of China.

Abstract

Insights

The combination of vancomycin (VAN) and piperacillin/tazobactam (PT) is associated with a higher risk of acute kidney injury (AKI). This finding suggests careful consideration of VAN and PT use in clinical practice to mitigate potential kidney damage.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Vancomycin (VAN) is a critical antibiotic for acute infections, often co-administered with piperacillin/tazobactam (PT).
  • The potential for this combination to increase the risk of acute kidney injury (AKI) compared to VAN alone is a subject of ongoing clinical debate.

Purpose of the Study:

  • To investigate the correlation between the concurrent administration of VAN and PT and the incidence of AKI.
  • To provide evidence-based insights into the nephrotoxic potential of this common drug combination.

Main Methods:

  • A meta-analysis was performed on eight observational cohort studies, encompassing 10,727 participants.
  • Comprehensive literature searches were conducted across major databases (PubMed, CBM, CNKI, WFDP, CSCD) up to April 2017.
  • Data extraction and risk of bias assessment were performed by two independent reviewers.

Main Results:

  • A statistically significant correlation was identified between the combined use of VAN and PT and an increased risk of AKI (OR 1.57; 95% CI, 1.13-2.01).
  • This association remained consistent even when comparing VAN and PT to VAN and cefepime (OR 1.50; 95% CI, 1.07-1.93).
  • Sensitivity analyses excluding lower-quality studies did not alter the observed correlation (OR 1.49; 95% CI, 1.06-1.92).

Conclusions:

  • The concurrent use of vancomycin and piperacillin/tazobactam is associated with an elevated risk of acute kidney injury.
  • Clinicians should carefully consider this increased nephrotoxicity risk when prescribing VAN and PT in combination.
  • Further research may be warranted to explore mechanisms and mitigation strategies for VAN-PT-induced AKI.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
797
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
489
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
365
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
979
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
346